2021 Drug Formulary Exclusions Continue to Reduce Therapy Choice…
Susan L. Lang outlines how pharma companies can navigate drug formulary exclusions, numbers of which have been rising in recent years, and ensure that…
Tagged with Opinion
CADTH CEO Suzanne McGurn on the Key Challenges in HTA Today
In conversation in the October edition of DIA’s Global Forum magazine, Canadian Agency for Drugs and Technologies in Health (CADTH) CEO Suzanne…
PMDA Chief Executive Yasuhiro Fujiwara on Regulatory Utilisation…
Writing in the October edition of DIA’s Global Forum magazine, Chief Executive of Japan’s Pharmaceuticals and Medical Devices Agency (PMDA)…
The 2021 WHO Essential Medicines List: How Pharma Can Turn…
Shawview Consulting's Brendan Shaw examines the WHO's recently released updated Essential Medicines List. Shaw highlights some of the key trends and…
NORD’s Breakthrough Summit: Listening to the Rare Disease…
The National Organization for Rare Disorders (NORD) is set to host its annual Rare Diseases and Orphan Products Breakthrough Summit on October…
China Drug Approvals at Record High for 2020
The following is an overview from Accestra Consulting* of Part 2 of China’s Center for Drug Evaluation (CDE)’s 2020 reporting, including an…
PhRMA COO: Removing Protections in Medicare Would Harm Seniors
PhRMA’s Lori Reilly warns that, as US policymakers seek to reduce drug prices, they must avoid policies that reduce access and choice. …
Flu Vaccination More Important Than Ever to Ensure Global…
Paula Barbosa, head of influenza policy and advocacy at the IFPMA and board member of the #TogetherAgainstFlu campaign, looks ahead to what could be a…
Norway’s New Health Data Sharing Platform: A Boost for Patients…
Norway has been a global frontrunner in collecting health data and building unique registries for decades but has struggled to utilise and benefit…
Regulatory Cooperation & Joint Assessments in ASEAN
Writing in the September edition of DIA’s Global Forum magazine, Rosilawati Ahmad of Malaysia's National Pharmaceutical Regulatory Agency;…
Concrete Steps Toward National Pharmacare in Canada
Writing in the September edition of DIA's Global Forum magazine, Dr Judith Glennie examines the specific steps that have been taken in the journey…
Sweden as a Global Testbed for AMR Incentive Models
Anders Blanck, CEO of Lif, the trade association for the research-based Swedish pharmaceutical industry, writes about the challenges the world faces…
